课题基金 / 基金详情

Genetics of SV40 Entry and Minichromosome Transport

Genetics of SV40 Entry and Minichromosome Transport
SV40 进入和微型染色体运输的遗传学
批准号:
6820658
负责人:
Leonard C. Norkin
金额:
$25.42万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2009-06-30

项目摘要

项目成果

Leonard C. Norkin的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):猿猴病毒40(SV 40)通过与质膜MHC I类分子结合,然后通过小窝介导的独特机制(而不是网格蛋白包被的小窝)进入细胞,从而感染细胞。不寻常的SV 40进入途径的一个显著特征是它将病毒转运到内质网(ER),而不是核内体。重要的是,ER是SV 40内部衣壳蛋白VP 2和VP 3与病毒体分离的位点。然后VP 2/3进入胞质溶胶,而病毒体和主要衣壳蛋白VP 1留在ER中。该项目的目标是研究SV 40的分子特征,这些分子特征是细胞识别、进入和细胞内运输的基础,并阐明SV 40基因组(微型染色体)的释放过程及其向细胞核的运输。具体目标如下。首先,确定SV 40衣壳蛋白在SV 40的结合和细胞内运输中的作用,并确定这些蛋白的分子特征,这些蛋白是这种病毒不寻常的进入和运输的基础。第二,确定野生型SV 40病毒粒子释放微型染色体的细胞区室和微型染色体进入细胞核的途径。第三,研究VP 2和VP 3在微染色体脱膜和转运过程中的作用。这里的一个特别的目的是确定肉豆蔻化VP 2是否在这些事件中起作用。第四,确定细胞骨架是否在将微型染色体转运到细胞核中起作用。如果是这样,那么将进行实验以鉴定相关的马达蛋白,并评估VP 2/3在细胞因子介导的转运过程中的可能作用。 实验程序将利用共聚焦显微镜,其中病毒粒子,病毒蛋白和细胞器将通过免疫荧光染色可视化。在一些实验中,荧光原位杂交(FISH)将与免疫细胞化学相结合,以观察细胞器,细胞骨架和病毒蛋白的微型染色体。实验样品将包括野生型病毒、构建的病毒突变体和体外组装的含有病毒蛋白质特定组合的病毒颗粒。 最近的研究报告表明,SV 40感染可能导致人类肿瘤性疾病,包括间皮瘤、骨肉瘤、儿童脑肿瘤和非霍奇金淋巴瘤。
英文摘要
DESCRIPTION (provided by applicant): Simian virus 40 (SV40) infects cells by binding to plasma membrane MHC class I molecules and then entering via a unique mechanism mediated by caveolae, rather than clathrin-coated pits. A notable feature of the unusual SV40 entry pathway is that it transports the virus to the endoplasmic reticulum (ER), rather than to endosomes. Importantly, the ER is the site in which the SV40 internal capsid proteins VP2 and VP3 separate from virions. VP2/3 then enter the cytosol, whereas virions and the major capsid protein VP1 remain in the ER. The goal of this project is to investigate the molecular features of SV40 that underlie cell recognition, entry and intracellular trafficking, and to clarify the process of release of the SV40 genome (the minichromosome) and its transport to the nucleus. Specific objectives are as follows. First, to determine the roles of the SV40 capsid proteins in the binding and intracellular trafficking of SV40, and to identify the molecular features of those proteins that underlie the unusual entry and trafficking of this virus. Second, to identify the.cellular compartment.into which wild type SV40 virions release their minichromosomes and the route of the minichromosomes to the nucleus. Third, to characterize the function of VP2 and VP3 in the processes of uncoating the minichromosome and transporting it out of the ER. A particular aim here is to determine whether myristylated VP2 has a role in these events. Fourth, to determine whether the cellular cytoskeleton has a role in transporting the minichromosome to the nucleus. If it does, then experiments will be carried out to identify the relevant motor proteins and to evaluate the possible role of VP2/3 in the cytoskeleton-mediated transport process. Experimental procedures will make use of confocal microscopy, in which virions, virus proteins, and cellular organelles will be visualized by immunofluorescent staining. In some experiments, fluorescent in situ hybrization (FISH) will be combined with immunocytochemistry, to visualize minichromosomes with respect to cellular organelles, the cytoskeleton, and virus proteins. Experimental samples will include wild type virus, constructed virus mutants, and in vitro assembled virus particles that contain specific combinations of virus proteins. Recent studies report evidence that SV40 infection may lead to neoplastic disease in humans, including mesotheliornas, osteosarcomas, childhood brain tumors, and non-Hodgkin's Iymphoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetics of SV40 Entry and Minichromosome Transport
Genetics of SV40 Entry and Minichromosome Transport
Genetics of SV40 Entry and Minichromosome Transport
Genetics of SV40 Entry and Minichromosome Transport
海外基金